MedTrace Logo

Shock Wave Therapy for Lower Limb Lymphedema

NCT06454734 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2025-07-31

No results posted yet for this study

Summary

This is a double-blind randomized clinical trial to compare the effect of shock wave therapy on lower limb lymphedema. There are two arms: A) complex decongestive therapy + extracorporeal shock waves therapy; B) complex decongestive therapy plus placebo extracorporeal shock waves.

Conditions

  • Lymphedema, Lower Limb

Interventions

DEVICE

Extracorporeal shock wave therapy by radial device

Patients will receive treatment by extracorporeal shock waves therapy (ESWT).

DEVICE

Placebo extracorporeal shock wave therapy by radial device

Patients will receive treatment sham extracorporeal shock waves.

OTHER

DLT

Patients will receive treatment with decongestive lymphatic therapy (DLT: manual lymphatic drainage, compression)

Sponsors & Collaborators

  • Parc de Salut Mar

    lead OTHER

Principal Investigators

  • Roser Belmonte, MD, PhD · Hospital del Mar

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-05-28
Primary Completion
2026-07-31
Completion
2026-12-31

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06454734 on ClinicalTrials.gov